Yu Xi, Li Shenglan, Ke Shuai, Ye Chenglin, Wang Qinghua, Wang Huaxin, Wang Lei
Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Department of Radiography, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
J Cancer. 2024 Apr 19;15(11):3242-3253. doi: 10.7150/jca.94343. eCollection 2024.
Bladder Cancer (BCa) is one of the most common cancers of the urinary system. Colony-stimulating factor 2 (CSF2) is involved in many cancers, but not BCa. We investigated the effect of CSF2 on BCa in this study and the underlying molecular mechanisms. CSF2 mRNA levels in BCa were analyzed using the Cancer Genome Atlas (TCGA) database. Western blot was conducted to verify CSF2 expression in BCa tissue samples and cell lines. The effect of CSF2 on the growth of BCa cells was assessed by CCK8 and colony formation. To determine the migration and invasion capabilities of BCa cells, transwell analysis and wound healing assays were conducted. Next, western blot was used to explore the underlying mechanism. In the end, a xenografted BCa mouse model was established to examine the effects of CSF2 on tumorigenesis . Results showed that CSF2 mRNA was upregulated in BCa samples. Knocking down CSF2 significantly inhibited the proliferation and tumorigenesis of BCa cells and . Mechanism analysis revealed that CSF2 knockdown inhibited the proliferation and invasion of BCa cells via AKT/mTOR signaling. Based on these results, CSF2 promotes the proliferation and tumorigenesis of BCa.
J Exp Clin Cancer Res. 2022-5-17
World J Surg Oncol. 2023-8-22
Front Cell Dev Biol. 2021-10-22
J Recept Signal Transduct Res. 2022-4
Theranostics. 2025-7-25
Discov Oncol. 2025-4-9
CA Cancer J Clin. 2024
Front Pharmacol. 2021-10-29
Int J Biol Sci. 2021-6-26
Ann Transl Med. 2021-4
Nat Rev Cancer. 2021-2
Front Pharmacol. 2020-8-27